NOVO-B.CO Trial readout: Monday, November 30, 2026

EventTrial readout
DateMonday, November 30, 2026
MarketEU listing
SourceCT.gov registry · confidence 95% · primary source ↗

Est. Completion: 2026-11-30. Status: ENROLLING_BY_INVITATION. Title: Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.

Every date on this page is free — forever.

A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.